Breaking Finance News

A statement released earlier today by Off Wall Street about Haemonetics Corporation (NYSE:HAE) raises the target price to $24.00

Haemonetics Corporation (NYSE:HAE) had its price target upped to $24.00 by Off Wall Street in an issued report announced 10/14/2016. The bumped up target suggests a possible downside of -0.31% based on the company's previous close.

Only yesterday Haemonetics Corporation (NYSE:HAE) traded -4.21% lower at $34.61. HAE’s 50-day average is $36.81 and its 200-day moving average is $32.61. With the last closing price up 6.11% from the 200-day moving average, compared to the S&P 500 which has decreased -0.01% over the same time period. 480,490 shares of HAE traded, up from an avg. volume of 320,906

Performance Chart

Haemonetics Corporation (NYSE:HAE)

With a total market value of $0, Haemonetics Corporation has 52 week low of $25.98 and a 52 week high of $38.06 .

In addition to Off Wall Street reporting its stock price target, a total of 9 brokerages have issued a ratings update on the company. The average stock price target is $30.89 with 3 brokerages rating the stock a strong buy, 1 brokerage rating the stock a buy, 6 brokerages rating the stock a hold, 2 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.

Brief Synopsis On Haemonetics Corporation (NYSE:HAE)

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides various products to customers involved in the processing, handling and analysis of blood. The Company's segments include Japan, EMEA, North America Plasma and All Other. Haemonetics provides plasma collection systems and software, which enable plasma fractionators to make pharmaceuticals. The Company enables plasma collection customers to source from it a range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and disposables, plasma collection containers and intravenous solutions, such as saline. Haemonetics offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products. The Company offers a range of blood management solutions. The Company has a suite of integrated software solutions, which include solutions for blood drive planning and blood collection.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *